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Over the past 15 years, epidemiologic studies
consistently have demonstrated an association
between ambient levels of ambient air pollu-
tants and daily cardiovascular mortality, hospi-
tal admissions, and emergency room visits.
Associations often have been observed at levels
below the National Ambient Air Quality
Standards (NAAQS) for various pollutants
(Burnett et al. 1999; Linn et al. 2000; Mar et
al. 2000; Moolgavkar 2000; Morris and
Naumova 1998; Morris et al. 1995; Poloniecki
et al. 1997; Schwartz 1997, 1999; Schwartz
and Morris 1995). Particle air pollutants, in
particular, have been associated with cardiac
outcomes (Samet et al. 2000; Schwartz 1999;
Schwartz and Morris 1995; Zanobetti et al.
2000), but gaseous pollutants such as carbon
monoxide (Morris et al. 1995), nitrogen diox-
ide (Linn et al. 2000; Moolgavkar 2000;
Poloniecki et al. 1997), and ozone (Burnett et
al. 1999; Goldberg et al. 2001; Wong et al.
1999) also have been associated. Toxicologic
studies in diseased animals and monitoring
studies in humans indicate that preexisting
heart or respiratory disease might be related to
the association of respirable particulate matter
and cardiac outcomes (Godleski 2000; Gold
et al. 2001; Gordon and Riebman 2000; Pope
et al. 1999b; Watkinson et al. 1998). Recent
epidemiologic studies also have shown that
persons with preexisting cardiopulmonary con-
ditions are at increased risk for adverse cardiac
health events (Kwon et al. 2001; Zanobetti et
al. 2000) associated with ambient particulate
matter. The present study investigates the
modifying effect of secondary diagnoses of
arrhythmia (sARR) and congestive heart failure
(sCHF) on the relationship between hospital
admissions for ischemic heart disease (IHD)
and ambient air pollutants among members of
a large health maintenance organization who
reside in Southern California.
Methods
Subjects. This study included residents who
were Southern California Kaiser Permanente
(SCKP) members at any point from 1988 to
1995 and who lived within 20 km of one of
ﬁve particle air pollution monitors used in a
1995 intensive particulate matter monitoring
data collection. The study area included the
most densely populated areas of the South
Coast Air Basin (SoCAB), which includes the
city of Los Angeles, and contained an annual
average of 1,515,776 members over the 8-year
study period (70.3% of SCKP membership).
The air basin is known both for summertime
photochemical smog and relatively high 
wintertime NO2 and particulate matter con-
centrations. The study area extended from
the Pacific coast of California east to the
Riverside/San Bernadino metropolitan areas,
and from the San Fernando Valley to the
north to Newport Beach to the south.
Outcomes. Daily hospital admissions for
IHD [International Classification of Diseases,
Revision 9 (ICD-9) codes 410–414] alone (no
secondary diagnosis; sNO) or with accompa-
nying diagnoses of sCHF (ICD-9 code 428)
and/or sARR (ICD-9 codes 426 and 427)
were the main outcomes studied. Discharge
diagnoses were used to classify each admission.
Almost half of those with sCHF also had
sARR. To evaluate the effect of each sec-
ondary diagnosis, admissions among those
with either secondary condition were divided
into three mutually exclusive groups: those
with either an sARR or sCHF diagnosis, and
those with both secondary diagnoses. ICD-9
codes 410 [myocardial infarction (MI)] and
411 (other acute and subacute forms of
IHD) were the primary diagnoses in 71.6%
of admissions. These two diagnoses were not
evenly distributed among sCHF, sARR, and
sNO admission groups. Therefore, these spe-
ciﬁc admission diagnoses were also studied.
Air pollutants/exposure assignment.
Routine monitoring data for criteria air pollu-
tants from 1988 to 1995 in the SoCAB were
acquired from the South Coast Air Quality
Management District (SCAQMD). Hourly
concentration data for O3, NO2, and CO
were obtained from a network of 25–35 mon-
itoring stations in the SoCAB. Daily mass
concentrations of particles with aerodynamic
diameters ≤ 10 µm (PM10) were measured at
20 sites every 6 days. Hourly meteorologic
data for temperature and relative humidity
were acquired from a network of 15 monitor-
ing stations in the region [from the National
Climatic Data Institute (Asheville, NC) and
SCAQMD] (Figure 1). 
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Articles
We examined whether ischemic heart disease (IHD) hospital admissions were associated with air
pollutants in those with and without secondary diagnoses of arrhythmia (ARR) or congestive heart
failure (CHF). We assessed the occurrence of increased vulnerability among persons with these
conditions to daily variations in ozone, carbon monoxide, nitrogen dioxide, or particulate matter
≤ 10 µm in aerodynamic diameter (PM10). The study population consisted of members of a large
health maintenance organization residing in the South Coast Air Basin of California from 1988 to
1995. After adjustment for day of week, study year, and smoothing splines for day of study, tem-
perature, and relative humidity, CO and NO2 were both associated with admissions with the
greatest effects for CO. A 1-ppm increase in 8-hr average CO was associated with a 3.60% [95%
confidence interval (CI), 1.62–5.63%] increase in same-day IHD admissions in persons with a
secondary diagnosis of CHF, a 2.99% (95% CI, 1.80–4.19%) increase in persons with a sec-
ondary diagnosis of ARR, and a 1.62% (95% CI, 0.65–2.59%) increase in IHD admissions in
persons without either secondary diagnosis. Air pollution was most strongly associated with
myocardial infarction hospital admissions. The vulnerability of the secondary CHF subgroup may
be due to a greater prevalence of myocardial infarction primary diagnoses and not the modifying
effect of CHF. This study suggests that people with IHD and accompanying CHF and/or ARR
constitute a sensitive subgroup in relation to the effects of criteria ambient air pollutants associ-
ated with motor vehicle combustion. Key words: air pollution, arrhythmia, carbon monoxide, con-
gestive heart failure, hospital admissions, ischemic heart disease, nitrogen dioxide. Environ Health
Perspect 110:1247–1252 (2002).  [Online 29 October 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1247-1252mann/abstract.htmlThis analysis uses daily maximum 8-hr
average O3 (ultraviolet photometry) and CO
concentrations (nondispersive infrared pho-
tometry) and 24-hr average NO2 (gas-phase
chemoluminescence) and PM10 concentra-
tions (gravimetric analysis with a size-selective
inlet sampler).
To assign daily exposure for each pollu-
tant, the air basin was divided into 10 km × 10
km grids. Each Kaiser Permanente member in
the study area was assigned to a grid based on
the centroid of his or her residential ZIP code
on 1 January of each year. The study area
included 84 grids with SCKP members. Daily
pollutant exposures were interpolated to grid
centroids from up to three monitors weighted
by the inverse of distance to the grid centroid.
Each grid was assigned to one of seven meteo-
rologic subregions based on temperature and
humidity patterns in January and July over
the 8-year period. A recent article that pre-
sented a conceptual model of exposure mea-
surement error in time-series studies of air
pollution showed that measurement error was
reduced when exposures were weighted by
baseline risk levels (Zeger et al. 2000). For
IHD admissions, persons ≥ 60 years of age
have been suggested to be at greatest risk.
Therefore, the annual population of members
≥ 60 years of age residing in each grid was
used for risk-weighting daily exposures.
Analysis. Poisson regression with allowance
for overdispersion was used to model the rela-
tionships between daily health outcomes and
daily concentrations of ambient air pollutants.
Separate base models were developed for each
diagnostic subgroup within each region
because temporal patterns of outcomes differed
across the regions. Generalized additive models
(S-Plus; Insightful; Seattle, WA), with air pol-
lutants omitted, were developed with cubic B-
spline–smoothed terms for study day,
temperature, and relative humidity. Fixed
effects terms for year and day of week also were
evaluated. Each model included an offset term,
the log of the number of members residing in
the region on 1 January of each year, so that
effects could be interpreted as relative rates.
The base model was selected on the basis of
Akaike’s information criterion. After selection
of the base model, each pollutant was regressed
against daily admission counts in each of the
seven regions. Because there was no evidence
of heterogeneity where effect estimates were
statistically significant, effect estimates were
pooled based on inverse variance weights.
Pollutants lagged from 0 to 5 days, and 2–5-
day moving averages were tested.
Single pollutant analyses were repeated
for all pollutants restricted to days on which
PM10 was measured. Analyses also were
restricted to April through October of each
year, the months in which O3 concentrations
were elevated. Base models were developed
for the ozone season to account for the differ-
ences in periodicity and trend in the outcome
series. To examine potential effect modiﬁca-
tion by age group, admissions in those ≥ 40
years of age were divided into two age groups,
40–59 years and ≥ 60 years. Finally, analyses
with the mutually exclusive diagnostic groups
were conducted to help elucidate the modify-
ing effect of each cardiac condition.
Results
Over the 8-year period, there were 54,863
IHD admissions among SCKP members in
the study area. In 34.5% (n = 18,935) and
14.1% (n = 7,754) of admissions, there was a
diagnosis of sARR and/or sCHF, respectively.
Admissions were most frequent in those with-
out either secondary diagnosis (sNO; n =
31,760). The mean number of daily admis-
sions in each region was 1.6, 0.93, and 0.38
for the sNO, sARR, and sCHF subgroups,
respectively. About one-half of those with a
diagnosis of sCHF also had a diagnosis of
sARR (n = 3,766) (Table 1). Specific IHD
admission diagnoses were not evenly distrib-
uted among the diagnostic subgroups. Persons
with sCHF were more likely to have a primary
diagnosis of MI (61.9%) than were those with
a diagnosis of sARR (37.8%) or with sNO
(28.8%). The annual rate of IHD admissions
was 10-fold greater in the older age stratum
(29.9/1,000 vs. 2.5/1,000). However, the dis-
tribution of speciﬁc IHD diagnoses was similar
in each age stratum (Table 2).
IHD admission counts among people
with sARR diagnoses rose from 1988 to 1992
and then declined. IHD admissions with
sCHF diagnoses increased in winter and
decreased in summer, whereas admissions in
those with sNO diagnoses had little seasonal-
ity but increased over the 8-year period.
Admissions were most likely to occur on
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Table 1. Distribution of events and rates for each outcome among IHD hospital admissions.
Mean admissions per Percent region-days Total Average annual
Diagnoses region-day (range)  with 0 admissions admissions rate/1,000
Main secondary outcomes
sNO 1.6 (0.14–3.3) 34.8 31,760 2.62
sARR 0.93 (0.12–2.0) 50.4 18,935 1.56
sCHF 0.38 (0.03–0.87) 71.7 7,754 0.64
Mutually exclusive secondary outcomes
sARR, not sCHF 0.74 (0.10–1.7) 56.4 15,169 1.25
sCHF, not sARR 0.20 (0.06–0.45) 83.3 3,988 0.33
sARR and sCHF 0.18 (0.02–0.35) 84.3 3,766 0.31
Speciﬁc primary admission diagnoses
Acute MI 0.96 (0.28–2.12) 48.0 19,690 1.62
Other acute forms of IHD 0.95 (0.11–2.05) 49.7 19,460 1.60
Angina pectoris 0.26 (0.01–0.58) 79.0 5,327 0.79
Other forms of chronic IHD 0.50 (0.07–1.06) 69.4 10,199 0.69
Figure 1. Map of the study area with the locations of meteorologic (Met) regions and stationary air pollution
monitors.
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> 2100Mondays and least likely to occur on
Saturdays. Regions 1 and 3 contained 59.9%
of the population and contributed more than
one-half of the admissions for each subgroup.
Only 11.7% of the study population lived in
regions 2, 6, and 7. Admission rates were
highest in region 2 and lowest in region 4 for
each outcome (data not shown).
Table 3 shows the mean, median,
interquartile range, and range for each
weather and pollutant variable. Annual PM10
and daily O3 concentrations frequently
exceeded NAAQS. Annual PM10 concentra-
tions were > 50 µg/m3 25% of the time.
Eight-hour average O3 levels were > 80 ppb
on 16.5% of region-days. In contrast, daily
CO and annual NO2 concentrations rarely, if
ever, surpassed federal guidelines (0.09% and
0.00%, respectively). Concentrations for all
air pollutants declined over the study period.
Pollutant concentrations varied by
region, which reflects regional differences in
motor vehicle traffic, land use, and climate.
O3 concentrations were higher in the eastern
regions where temperatures were higher in
summer. CO and NO2 concentrations were
greatest in regions 3 and 4, partly because of
motor vehicle traffic in those regions
(SCAQMD 1997), and PM10 concentrations
were highest in region 5. CO and O3 had the
largest spatial variation and NO2 had the
least as measured by a comparison of mean
concentrations from 1988 to 1995 (data not
shown).
Partial correlations between pollutants are
presented in Table 4. PM10 was modestly
associated with CO (r = 0.15–0.40) and NO2
(r = 0.36–0.60) in all regions. NO2 was
highly correlated with CO (0.64–0.86). NO2
was positively associated with O3 in all but
region 6 (r = –0.16 to 0.42). PM10 was most
correlated with O3 in region 2 (r = 0.57), CO
in region 5, and NO2 in region 7 (r = 0.60).
Partial correlations of O3 and CO varied in
both sign and magnitude across the regions
but were generally low.
Table 5 presents the results of single pollu-
tant models based on same-day concentra-
tions. PM10 was not significantly related to
admissions at any of the lags and moving aver-
ages tested. O3 coefficients were all negative
and generally nonsignificant. CO and NO2
were both related to admissions in each sub-
group across a range of lags and moving aver-
ages, with strongest effects found for a 0-day
lag or 2-day moving average; effects were no
longer evident with days lagged 4 days or
more and 5-day moving averages. A 1-ppm
increase in 8-hr average CO was associated
with a 3.60% increase [95% conﬁdence inter-
val (CI), 1.62–5.63] in daily hospitalizations
for sCHF and a 2.99% change (95% CI,
1.80–4.19) in those with a diagnosis of sARR.
By contrast, in the group with sNO diagnosis,
hospital admissions increased only 1.6% with
a 1-ppm increase in CO. A 10-ppb increase in
NO2 was associated with a 2.3% change in
sCHF, a 1.8% change in sARR, and a 1.3%
change in sNO admissions. Two pollutant
models with CO and NO2 would have been
unstable because of their high correlation in
some regions and so were not evaluated.
Associations were reduced in magnitude
and were nonsigniﬁcant for CO and NO2 on
days on which PM10 was measured (21% of
region-days). O3 coefficients remained non-
signiﬁcant. Because there might not have been
sufﬁcient days of analysis to detect PM10 asso-
ciations, given the number of daily admissions
in this population, PM10 was not included in
other sensitivity analyses.
O3 coefficients remained nonsignificant
even when the analysis was restricted to
months in which O3 was elevated (April
through October). However, CO and NO2
associations were generally reduced in magni-
tude and were nonsigniﬁcant possibly because
of the large loss of days and/or loss of tempo-
ral variability in CO and NO2 concentrations
during the O3 season.
When the analysis was restricted to per-
sons ≥ 60 years of age, CO and NO2 rela-
tionships with sARR and sCHF admissions
were similar to the main analysis, whereas
effects with the sNO subgroup were greater
(Table 6). A 10-ppb increase in NO2 was
associated with a 2.4% (95% CI, 1.02–3.71)
increase in admissions. When comparing the
three subgroups, the percentage increase in
admissions with CO was still greatest among
those with sCHF. A 1-ppm increase in 8-hr
average CO concentrations was associated with
a 2.9% increase in sCHF admissions (95% CI,
0.79–5.1). In the younger age group, CO
effects were slightly greater in the sARR sub-
group (3.06%; 95% CI, 0.56–5.61%) and
much greater in persons with sCHF (8.02%;
95% CI, 2.95–13.3%) relative to the older
age group. Air pollutants were not associated
with sNO admissions in the 40–59-year age
group.
Effects on sCHF admissions were not due
to associated ARR. The effects of CO and
NO2 were similar when admissions in those
with ARR were removed from the analysis.
Effect sizes among those with both secondary
conditions were not greater than those for
having sCHF or sARR alone (Table 7). Based
on mutually exclusive diagnostic groups, the
same rank order in magnitude of effects was
observed, with the strongest effects in those
with diagnoses of sCHF without sARR and
the smallest effects in the sNO subgroup.
Although the magnitude of effect for a
1-ppm increase in CO was greater than that
for a 10-ppb NO2 increase, an increase in
NO2 of 10 ppb or more occurred almost
twice as often (15.0% of region-days) as a
1-ppm CO increase (8.3% of region-days).
Increases equal to or greater than the span of
the interquartile range occurred about half as
often for both of these pollutants (Table 8).
Articles • Air pollution and ischemic heart disease
Environmental Health Perspectives • VOLUME 110 | NUMBER 12 | December 2002 1249
Table 2. Distribution of IHD primary diagnoses by secondary diagnosis and age group.
ICD-9 Secondary diagnosis (%) Age group (%)
Primary diagnosis code sARR sCHF sNO 40–59 years ≥ 60 years
Acute MI 410 37.8 61.9 28.8 34.5 36.6
Other acute and subacute forms of IHD 411 33.5 21.9 39.9 35.8 35.6
Angina pectoris 413 8.5 4.4 11.6  10.1 9.5
Other forms of chronic IHD 414 20.1 11.8 19.6 19.5 18.3
Table 3. Distribution of air pollutants and weather variables.
Pollutant n Mean ± SD  Median IQR Range
8-Hr average CO (ppm) 20,454 2.07 ± 1.29 1.70 1.14–2.61 0.30–11.8
24-Hr average NO2 (ppb) 20,447 37.2 ± 15.7 34.8 25.6–45.8 3.68–138
8-Hr average O3 (ppb) 20,454 50.3 ± 30.1 43.2 27.6–67.2 0.00–206
PM10 (µg/m3) 4,311 43.7 ± 27.7 40.6 24.0–58.4 0.22–251
Minimum temperature (°F) 20,454 53.8 ± 8.41 54.4 47.8–60.4 15.8–77.2
24-Hr average relative humidity (%) 20,440 54.1 ± 13.8 56.1 45.2–63.4 11.9–89.5
Abbreviations: IQR, interquartile range; n, number of region-days of measurements.
Table 4. Partial correlations for each pollutant pair.a
Region
Pollutant pair 1 2 3 4 5 6 7
CO/NO2 0.83 0.65 0.84 0.72 0.80 0.86 0.64
CO/O3 0.06 –0.30 0.13 –0.20 0.28 –0.37 –0.23
CO/PM10 0.28 0.15 0.36 0.27 0.40 0.33 0.28
O3/NO2 0.27 0.25 0.42 0.34 0.54 –0.16 0.34
O3/PM10 0.20 0.57 0.30 0.33 0.43 0.20 0.48
NO2/PM10 0.36 0.53 0.46 0.50 0.53 0.42 0.60
aCorrelation remaining after adjustment for day of week, year, and smoothing splines of study day, minimum temperature,
and average relative humidity using the base model for ischemic heart disease admissions.Discussion
Numerous studies have demonstrated an asso-
ciation between ambient air pollutants and
hospital admissions for cardiovascular diseases.
Few studies have investigated the subsets of
such patients who might be at particular risk
for hospital admission. This study demon-
strates that, among persons admitted to the
hospital with a primary diagnosis of IHD, the
presence of sCHF or sARR substantially
increases the risk of hospitalization associated
with air pollution, with greatest susceptibility
among those with a diagnosis of sCHF.
CO and NO2, at concentrations well
below NAAQS, were associated with admis-
sions in each diagnostic subgroup of IHD
admissions. The greatest effects were found
for both pollutants with same-day and 2-day
moving average concentrations. Because ambi-
ent concentrations of these two pollutants
were highly correlated, the independent con-
tribution of each could not be evaluated in
two pollutant models. O3 was not associated
with admissions in any subgroup, even when
the analysis was restricted to months when
ambient O3 concentrations were at their high-
est levels. Although PM10 was not associated
with IHD admissions, it was only measured
every 6 days. When analyses were restricted to
the days on which PM10 was measured, none
of the pollutants were associated with admis-
sions. Because there might have been an
insufficient number of monitoring days for
particulate air pollution (an average of 615
noncontiguous days for each series), a PM10
association cannot be ruled out. CO and
NO2 were probably not surrogates of PM10
exposure, however, because PM10 was less
correlated with CO and NO2 than the two
pollutants were with one another.
Almost one-half of persons with sCHF
admissions also had a diagnosis of sARR.
However, larger effects in the sCHF subgroup
were not due to associated sARR diagnoses;
sCHF effects were similar when persons who
also had diagnoses of sARR were removed
from the analysis. In addition, persons with
both secondary diagnoses were not at
increased risk relative to persons with either
sCHF or sARR.
Two primary diagnoses accounted for
72% of all admissions, MI and “other acute
IHD.” Persons with a diagnosis of sCHF
were about twice as likely to have a primary
diagnosis of MI than were persons from the
other two subgroups. Effect estimates were
71% greater for MI than for other acute
IHD. Therefore, the vulnerability of the
sCHF subgroup may be due to the greater
prevalence of the MI diagnosis and not the
modifying effect of CHF.
The greater effect estimates among the
sCHF and sARR subgroups could reflect
solely the independent associations between
air pollution and CHF and ARR. There are
two arguments against this explanation. First,
effects, although smaller, were present among
persons with sNO diagnoses. Second, in ear-
lier studies, hospital admissions for CHF and
ARR were not more strongly associated with
CO or NO2 than MI, angina, or the group of
IHD admissions (Linn et al. 2000; Poloniecki
et al. 1997).
Levy et al. (2001) used a case–crossover
design to examine the association of particle air
pollution with out-of-hospital cardiac arrest.
Patients with a history of cardiac disease,
including ARR, CHF, or prior MI, were
excluded. In this relatively healthy population,
none of the air pollutants was associated with
subsequent MI. Presumably their cases were
healthier than any of the subgroups in this
study, including the sNO subgroup, because
only cases of ﬁrst MI were included. More than
half of their study population was younger than
61 years. In this study, air pollution was not
signiﬁcantly related to admissions in persons
younger than 60 years without ARR or CHF.
Zanobetti et al. (2000) examined the
modifying effect of secondary diagnoses and
prior cardiorespiratory hospitalizations in
associations between PM10 and cardiorespira-
tory admissions. No other pollutants were
investigated. Associations of daily PM10 and
cardiovascular hospitalizations were modiﬁed
by previous hospital admissions for conduc-
tion disorders or dysrhythmias. Prior admis-
sion for CHF and MI did not increase risk of
a subsequent PM-associated cardiovascular
hospitalization.
CO has been associated with primary
admissions for CHF, IHD, and ARR in sev-
eral studies (Burnett et al. 1997; Morris and
Naumova 1998; Morris et al. 1995; Schwartz
and Morris 1995). Increases in daily NO2
concentrations have also been associated with
increased admissions for speciﬁc cardiac con-
ditions (Burnett et al. 1999; Linn et al. 2000;
Ye et al. 2001). In most of these studies, same-
day or 1-day lagged concentrations had the
strongest association with admissions. CO at
the monitor is poorly correlated with personal
exposure relative to other criteria air pollutants
in cross-sectional studies (Akland et al. 1985).
The lack of association of particles with
IHD admissions in this study is in contrast to
several other epidemiologic studies (Burnett
et al. 1995; Linn et al. 2000; Lippmann et al.
2000). However, particulate matter was not
associated with admissions in London
(Atkinson et al. 1999) or Birmingham (UK)
(Wordley et al. 1997). 
Recently, mechanisms have been proposed
to explain observed associations of particle air
pollution with cardiovascular morbidity and
mortality. One hypothesis is that particles
trigger the production of inﬂammatory medi-
ators, which in turn affects procoagulants
(e.g., fibrinogen, factor VII) and viscosity
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Table 5. Percentage increase (95% CI) in IHD hospital admissions with increasing concentrations of air pollutants,a 0–2-day lags, and 2–4-day moving averages.
Lags Moving averages
Type of admission/pollutant 0-day 1-day 2-day 2-day 3-day 4-day
sARR admissions
CO (ppm) 2.99 (1.80–4.19)* 1.51 (0.37–2.66)* 1.26 (0.15–2.38)* 2.66 (1.40–3.94)* 2.59 (1.27–3.92)* 2.25 (0.90–3.63)*
NO2 (ppb) 1.81 (0.78–2.85)* 0.84 (–0.18–1.87) 0.61 (–0.41–1.64) 1.43 (0.32–2.55)* 1.50 (0.31–2.70)* 1.35 (0.09–2.62)*
O3 (ppb) –0.43 (–1.07–0.21) –0.40 (–1.04–0.25) –0.80 (–1.44––0.15)* –0.47 (–1.14–0.21) –0.67 (–1.37–0.03)  –0.91 (–1.63––0.18)
PM10 (µg/m3)0 . 59 (–0.71–1.91) 0.46 (–0.86–1.80) –0.04 (–1.37–1.31)
sCHF admissions
CO (ppm) 3.60 (1.62–5.63)* 3.34 (1.48–5.22)* 1.90 (0.11–3.72)* 4.23 (2.13–6.37)* 4.14 (1.96–6.37)* 4.07 (1.81–6.38)*
NO2 (ppb) 2.32 (0.69–3.98)* 2.13 (0.52–3.77)* 0.90 (–0.70–2.52) 2.63 (0.87–4.41)* 2.47 (0.59–4.39)* 2.24 (0.26–4.22)*
O3 (ppb) –0.08 (1.25–1.10) –0.30 (–1.50–0.93) –0.10 (–1.31–1.13) –0.22 (–1.50–1.07) –0.24 (–1.61–1.14) –0.60 (–2.03–0.85)
PM10 (µg/m3) –0.62 (–1.77–0.55) –0.45 (–1.60–0.71) –0.36 (–1.52–0.82)
sNO admissions
CO (ppm) 1.62 (0.65–2.59)* 1.45 (0.54–2.37)* 0.92 (0.04–1.82)* 1.83 (0.80–2.86)* 1.79 (0.72–2.87)* 1.82 (0.71–2.94)*
NO2 (ppb) 1.30 (0.51–2.10)* 1.43 (0.65–2.22)* 0.75 (–0.03–1.53) 1.63 (0.77–2.49)* 1.35 (0.43–2.27)* 1.30 (0.30–2.31)*
O3 (ppb) –0.61 (–1.23–0.02) –0.21 (–0.76–0.34) –0.25 (–0.80–0.30) –0.40 (–0.97–0.18) –0.40 (–1.00–0.21) –0.62 (–1.26–0.02)
PM10 (µg/m3) –0.25 (–1.23–0.75) 0.04 (–0.97–1.06) 0.18 (–0.82–1.20)
aPercentage increase in admissions with a 1 ppm increase in CO, a 10 ppb increase in NO2 or O3 or a 10 µg/m3 increase in PM10; for example, a 1-ppm increase in same-day CO is associ-
ated with a 2.99% increase in IHD admissions in persons with a sARR. For each lag, pollutant coefﬁcients from seven regions were pooled weighted by the inverse of the standard error.
Before pooling, estimates were adjusted for day of week, year, and region-speciﬁc cubic B-spline smooths of study day, temperature, and relative humidity.
*Statistically signiﬁcant association (p < 0.05).(Seaton et al. 1995). Similarly, particles have
been hypothesized to affect autonomic func-
tion of the heart (Peters et al. 2000a). Both
hypotheses are supported by several studies in
animals and humans (Creason et al. 2001;
Liao et al. 1999; Peters et al. 1997, 2000a,
2000b; Pope et al. 1999a, 1999b; Schwartz
2001; Watkinson et al. 1998).
Although these hypotheses were developed
to explain cardiovascular morbidity and mor-
tality associated with particulate air pollution,
similar mechanisms might be true for both
CO and NO2. In controlled human exposure
studies using broncheoalveolar lavage, acute
NO2 exposures as dilute as 1 mg/m3 were asso-
ciated with increased production of inﬂamma-
tory mediators (Jeffrey 1999). Both NO2 and
CO have been associated with increased con-
centrations of inﬂammatory markers in human
exposure and epidemiologic studies. In
London ofﬁce workers, NO2 and CO levels on
the day before were associated with increased
fibrinogen concentrations (Pekkanen et al.
2000). Plasma viscosity was increased during
an air pollution episode in Germany in which
levels of sulfur dioxide and total suspended
particles were elevated. However, in that
study, CO concentrations were also positively
associated with plasma viscosity over the
whole study period (CO did not increase
appreciably during the air pollution episode)
(Peters et al. 1997). Based on data from the
Third National Health and Nutrition
Examination Survey (NHANES III), a repre-
sentative sample of the U.S. adult population,
NO2 was associated with increased platelet
counts and ﬁbrinogen but not increased white
blood cells, whereas PM10 was associated with
all three outcomes (Schwartz 2001).
Particles have been associated with
decreased heart rate variability and slightly
increased heart rate in two small studies (Gold
et al. 2001; Pope et al. 1999b). CO and NO2
were not associated with increased heart rate
and decreased heart rate variability, however
(Gold et al. 2001). Peters et al. (2000a) exam-
ined the relationship of air pollution to car-
diac ARR incidence among 100 cardiac
patients with implanted defribillators.
Particles, O3, CO, SO2, and NO2 were stud-
ied. Only NO2 (lagged 1 day or a 5-day mov-
ing average) was associated with ARRs that
triggered the deﬁbrillator in these patients.
Carboxyhemoglobin (COHb) levels of 2%
(produced in 10% of the population in
response to 8-hr average 9-ppm CO concen-
trations) were associated with shorter time to
exercise-induced angina and shorter ST inter-
vals among 62 nonsmoking volunteers with
IHD (Allred et al. 1989). CO also has been
shown to impair myoglobin’s oxygen transport
and storage capacity. The resulting reduction
in oxygen in the myocardial circulation could
increase the likelihood of angina and MI.
Allred et al. (1989) hypothesized that CO-
associated decreases in pO2 (partial pressure of
O2) might raise the risk of ventricular ﬁbrilla-
tion in patients with preexisting ischemia.
However, CO was not associated with
increased ectopic beats at COHb of 3% or 5%
(Maynard and Waller 1999). 
The known increase in wall tension in
CHF and its associated effects on epicardial
circulation certainly also could place persons
with CHF at greater risk for air pollution
associated acute MI.
Conclusions 
This is the ﬁrst epidemiologic study showing
that people with IHD and accompanying
CHF and/or ARR constitute a sensitive sub-
group in relation to the effects of criteria air
pollutants associated with motor vehicle com-
bustion. Persons with a diagnosis of sCHF
were at greatest risk. There was insufficient
power to determine whether a higher propor-
tion of MI diagnoses in those groups explained
the added risk of these comorbid conditions.
This study should be repeated in an area with
sufﬁcient events to analyze MI admissions in
persons with and without diagnoses for sCHF
or sARR. Although an effect of PM10 could
not be ruled out, same-day and 2-day moving
average concentrations of CO and NO2 were
consistently associated with admissions in each
subgroup. The major source of ambient CO
and NO2 in the study area is motor vehicles.
Therefore, either or both pollutants might be
surrogates for the pollution mix associated
with motor vehicle combustion.
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